Valuation: ZIM Laboratories Limited

Market Cap 6.56B 67.94M 59.54M 55.32M 50.82M 95.73M 97.22M 658M 257M 3.21B 255M 250M 11.08B P/E 2025
32.1x
P/E 2026 50.3x
Enterprise Value 7.42B 76.88M 67.38M 62.6M 57.5M 108M 110M 745M 291M 3.63B 289M 282M 12.54B EV / Sales 2025
1.34x
EV / Sales 2026 1.09x
Free-Float
28.79%
Yield 2025 *
-
Yield 2026 -
1 day-2.00%
1 week+3.55%
Current month-1.45%
1 month+2.55%
3 months+46.16%
6 months+72.92%
Current year+70.40%
1 week 122.5
Extreme 122.5
125.5
1 month 111.5
Extreme 111.5
133.95
Current year 59.72
Extreme 59.72
133.95
1 year 59.72
Extreme 59.72
133.95
3 years 59.72
Extreme 59.72
151.75
5 years 36.37
Extreme 36.3667
151.75
10 years 14
Extreme 14
151.75
Manager TitleAgeSince
Chief Executive Officer - 2001-12-31
Director of Finance/CFO - 2019-03-31
Director of Finance/CFO - 1990-12-31
Director TitleAgeSince
Chairman - 1989-12-31
Director/Board Member - 1990-12-31
Director/Board Member - 2012-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-2.00%+3.55%+2.47%+2.08% 68.11M
-0.96%+0.02%+14.81%+77.10% 48.88B
-0.99%-0.27%+66.69%+108.95% 35.72B
-1.21%-1.60%-3.99%+34.91% 12.02B
-1.47%-0.64%+16.11%+83.68% 11.84B
-0.37%+0.94%+34.42%+136.73% 8.95B
+0.33%-1.13%+50.36%-5.96% 6.91B
-0.34%-2.41%+14.20%+33.03% 6.78B
-1.88%-4.56%+0.69%+192.09% 6.57B
-2.47%-5.28%-33.67%+6.76% 5.81B
Average -1.14%-1.64%+16.21%+66.94% 14.35B
Weighted average by Cap. -1.01%-0.36%+26.55%+82.05%

Financials

2025 2026
Net sales 3.79B 39.27M 34.41M 31.98M 29.37M 55.33M 56.19M 381M 149M 1.85B 147M 144M 6.41B 3.74B 38.78M 33.98M 31.58M 29M 54.64M 55.49M 376M 147M 1.83B 146M 142M 6.33B
Net income 122M 1.26M 1.1M 1.03M 942K 1.78M 1.8M 12.21M 4.78M 59.45M 4.73M 4.63M 206M 58.38M 605K 530K 492K 452K 852K 865K 5.86M 2.29M 28.53M 2.27M 2.22M 98.64M
Net Debt 1.16B 11.99M 10.51M 9.76M 8.97M 16.89M 17.16M 116M 45.44M 566M 45.01M 44.03M 1.96B 863M 8.94M 7.83M 7.28M 6.69M 12.59M 12.79M 86.63M 33.88M 422M 33.55M 32.83M 1.46B
Logo ZIM Laboratories Limited
ZIM Laboratories Limited is a pharmaceutical company. The Company develops, manufactures and supplies oral, solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) in various therapeutic segments. Its delivery solutions cover product conceptualization product development, filing for registration, manufacture, and supply of various pharmaceutical formulations. It is developing products in various therapeutic segments like, central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology and vitamins, minerals, and dietary supplements. Its technological capabilities include drug release modification, solubility and stability enhancement, taste masking and dosage form transformation. Its product offerings include finished formulations and pre-formulations intermediates, which include granules, pellets, taste-masked powders, dry suspensions, tablets, capsules, and oral thin films.
Employees
632
Date Price Change Volume
26-07-21 ₹122.50 -2.00% 400
26-07-20 ₹125.00 -0.36% 2,296
26-07-17 ₹125.45 +1.95% 8,530
26-07-16 ₹123.05 +1.99% 3,069
26-07-15 ₹120.65 +1.99% 5,681
  1. Stock Market
  2. Stocks
  3. ZIMLAB Stock